Page last updated: 2024-10-24

carbamazepine and Hypobetalipoproteinemias

carbamazepine has been researched along with Hypobetalipoproteinemias in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Hypobetalipoproteinemias: Conditions with abnormally low levels of BETA-LIPOPROTEINS (low density lipoproteins or LDL) in the blood. It is defined as LDL values equal to or less than the 5th percentile for the population. They include the autosomal dominant form involving mutation of the APOLIPOPROTEINS B gene, and the autosomal recessive form involving mutation of the microsomal triglyceride transfer protein. All are characterized by low LDL and dietary fat malabsorption.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sari, S1
Yilmaz, G1
Gonul, II1
Dalgic, B1
Akyol, G1
Giovannoni, I1
Francalanci, P1
Callea, F1

Other Studies

1 other study available for carbamazepine and Hypobetalipoproteinemias

ArticleYear
Fibrinogen storage disease and cirrhosis associated with hypobetalipoproteinemia owing to fibrinogen Aguadilla in a Turkish child.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:12

    Topics: Afibrinogenemia; Carbamazepine; Child, Preschool; Cholagogues and Choleretics; Cytochrome P-450 CYP3

2015